Displaying 13 - 24 of 31
Metabolism, Alcohol & Toxicity

Novo Nordisk: Navigating MASH patient care (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Personalised management of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk: Updates on the essence of MASH (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway

Webcasts
View
Metabolism, Alcohol & Toxicity

Simplifying the patient referral pathway in NASH: expert opinion

Webcasts
View
Metabolism, Alcohol & Toxicity

Discussion and Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and conclusion

Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH

Why we need to talk about NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Hepatic consequences of metabolic dysregulation: NAFLD and NASH

Webcasts
View
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients

Looking ahead: how to identify high-risk patients

Webcasts
View
Displaying 13 - 24 of 31